Distributions of all expression values and Top 1% of expressed Boundary features for libraries: PreTx_Un, PostTx_Un, PreTx_En, PostTx_En
Distribution of log2 expression values for library: PreTx_Un and data type: Boundary
Distribution of all expression values for the feature type: Boundary. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: PostTx_Un and data type: Boundary
Distribution of all expression values for the feature type: Boundary. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: PreTx_En and data type: Boundary
Distribution of all expression values for the feature type: Boundary. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: PostTx_En and data type: Boundary
Distribution of all expression values for the feature type: Boundary. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Top 1% of expressed Boundary features
The following table provides a ranked list of the most highly expressed Boundary features. Each column corresponds to an expression library. Each table cell contains the Gene Name (which links to the ALEXA-Seq gene record), followed by the Feature Name (which links to the feature's coordinates in the UCSC Genome Browser and displays expression data), the log2 expression value 'Exp' for the feature, and the percent expression value '% Exp' ([feature expression/gene expression]*100). Features that are NOT supported by an EST/mRNA sequence are indicated in bold. For exon junction features the number of exons skipped by the junction is indicated as 'Sn', where n is the number of exons skipped (e.g. S0 means no exons skipped, S1 means one exon skipped, etc.).
RANK | PreTx_Un (Gene | Feature | Exp | % Exp) | PostTx_Un (Gene | Feature | Exp | % Exp) | PreTx_En (Gene | Feature | Exp | % Exp) | PostTx_En (Gene | Feature | Exp | % Exp) |
1 | HBB | E3_Ab | 19.71 | 224.40% | HBB | E3_Ab | 19.31 | 251.22% | IGHA2 | E3_Db | 17.06 | 148.22% | IGHA2 | E3_Db | 18.48 | 440.08% |
2 | HBB | E4_Da | 17.47 | 47.69% | IGHA2 | E3_Db | 18.23 | 1152.31% | UBC | E2_Ak | 15.39 | 199.03% | IGHA1 | E2_Aa | 17.96 | 21.62% |
3 | IGHA2 | E3_Db | 15.95 | 110.93% | HBB | E4_Da | 16.06 | 26.40% | EEF1A1 | E4_Da | 15.27 | 633.23% | IGHA2 | E3_Da | 16.01 | 79.50% |
4 | UBC | E2_Ak | 13.91 | 214.48% | IGHA2 | E3_Da | 15.18 | 139.53% | UBC | E2_Da | 15.16 | 169.57% | UBC | E2_Da | 15.59 | 379.72% |
5 | UBC | E2_Da | 13.81 | 200.53% | D87017.2 | E2_Aa | 14.73 | 2890.02% | UBC | E2_Dj | 15.02 | 153.81% | UBC | E2_Ak | 15.37 | 326.98% |
6 | UBC | E2_Dj | 13.73 | 190.11% | UBC | E2_Ak | 14.57 | 314.69% | UBC | E2_Dk | 14.98 | 149.90% | UBC | E2_Dk | 14.89 | 235.04% |
7 | UBC | E2_Dk | 13.62 | 176.54% | UBC | E2_Da | 14.40 | 279.49% | HBB | E3_Ab | 14.85 | 358.29% | AC096663.1 | E2_Aa | 14.38 | 62617.29% |
8 | HLA-A | E6_Ac | 13.57 | 291.13% | UBC | E2_Dk | 14.13 | 232.20% | UBC | E2_Dc | 14.36 | 97.32% | UBC | E2_Dj | 14.38 | 164.79% |
9 | PTMA | E2_Ad | 12.91 | 241.27% | UBC | E2_Dj | 14.08 | 224.04% | UBC | E2_Dd | 14.25 | 90.22% | UBC | E2_Ab | 14.30 | 155.43% |
10 | AC092268.4 | E1_Da | 12.83 | 52229.17% | TMSB4X | E2_Da | 13.71 | 308.54% | TXNDC5 | E16_Da | 13.99 | 96.60% | UBC | E2_Dc | 14.25 | 150.76% |
11 | UBC | E2_Dd | 12.77 | 97.94% | EEF1A1 | E5_Db | 13.62 | 267.80% | UBC | E2_Ah | 13.56 | 55.90% | TXNDC5 | E16_Da | 14.22 | 120.83% |
12 | UBC | E2_Dc | 12.60 | 87.07% | S100A12 | E4_Da | 13.61 | 84.18% | HLA-A | E6_Ac | 13.34 | 197.96% | HSP90B2P | E1_Da | 13.76 | 195579.04% |
13 | EEF1A1 | E5_Db | 12.52 | 160.35% | AC002480.1 | E2_Aa | 13.43 | 16308.33% | UBC | E2_Af | 13.30 | 46.63% | HLA-A | E6_Ac | 13.72 | 402.58% |
14 | AC002480.1 | E2_Aa | 12.51 | 20658.19% | AL355076.5 | E3_Aa | 13.31 | 124108.03% | HBB | E4_Da | 13.02 | 100.53% | UBC | E2_Dd | 13.71 | 103.76% |
15 | RPS6 | E2_Dd | 12.39 | 147.44% | S100A12 | E4_Ab | 13.22 | 64.56% | TMSL3 | E1_Ab | 12.81 | 9343.66% | EEF1A1 | E5_Db | 13.66 | 204.46% |
16 | TXNDC5 | E16_Da | 12.28 | 92.07% | UBC | E2_Dc | 13.17 | 119.37% | HSP90B2P | E2_Da | 12.64 | 75817.82% | D87017.2 | E2_Aa | 13.66 | 1139.93% |
17 | EEF1A1 | E4_Da | 12.19 | 127.72% | UBC | E2_Ab | 13.08 | 111.91% | HSP90B3P | E3_Aa | 12.56 | 102854.39% | HSP90B2P | E2_Da | 13.62 | 177417.85% |
18 | GAPDH | E10_Da | 12.14 | 51.75% | TMSL3 | E1_Da | 13.03 | 2591.47% | IL2RG | E1_Ad | 12.43 | 119.87% | HSP90B3P | E3_Aa | 13.48 | 174263.35% |
19 | UBC | E2_Af | 11.90 | 53.33% | LCN2 | E2_Ac | 12.97 | 84.14% | RPS6 | E2_Dd | 12.30 | 259.49% | UBC | E2_Af | 13.44 | 85.74% |
20 | HLA-B | E9_Ab | 11.87 | 25.19% | TXNDC5 | E16_Da | 12.89 | 117.95% | AC135457.2 | E1_Ab | 12.28 | 202.44% | HBB | E3_Ab | 13.41 | 452.95% |
21 | UBC | E2_Ah | 11.85 | 51.55% | AL121759.25 | E1_Da | 12.89 | 107385.04% | ARF1 | E1_Ab | 12.16 | 156.92% | AC135457.2 | E1_Ab | 13.28 | 320.25% |
22 | AC087365.3 | E5_Aa | 11.83 | 8640.54% | UBC | E2_Dd | 12.67 | 84.28% | AHNAK | E5_Db | 12.13 | 215.44% | HSP90B3P | E2_Da | 13.21 | 144235.90% |
23 | TPT1 | E5_Da | 11.79 | 71.51% | HLA-A | E6_Ac | 12.65 | 229.74% | AC002480.1 | E2_Aa | 11.86 | 9112.87% | EEF1A1 | E4_Da | 13.16 | 144.77% |
24 | TPT1 | E1_Ac | 11.70 | 66.74% | UBC | E2_Af | 12.58 | 79.02% | EEF1A1 | E9_Da | 11.86 | 59.86% | HSP90B2P | E2_Aa | 13.14 | 127866.16% |
25 | HLA-A | E4_Da | 11.53 | 70.62% | HSP90B3P | E2_Da | 12.39 | 70361.26% | TPT1 | E5_Da | 11.66 | 87.84% | IL2RG | E1_Ad | 12.98 | 214.96% |
26 | TMSL3 | E1_Da | 11.51 | 2150.07% | HSP90B3P | E3_Aa | 12.31 | 66668.53% | TPT1 | E1_Ac | 11.59 | 83.41% | UBC | E2_Al | 12.79 | 54.67% |
27 | TMSB4X | E2_Da | 11.44 | 148.60% | EEF1A1 | E4_Da | 12.27 | 105.08% | EEF1A1 | E9_Ab | 11.45 | 45.10% | UBC | E2_Ah | 12.72 | 52.00% |
28 | TUBA1C | E5_Da | 11.31 | 541.38% | LCN2 | E2_Ab | 12.26 | 51.39% | HSPA8 | E7_Da | 11.45 | 59.63% | UBC | E2_Ac | 12.71 | 51.59% |
29 | S100A12 | E4_Ab | 11.15 | 57.18% | AC096663.1 | E1_Da | 12.23 | 6593.45% | COPEB | E2_Da | 11.44 | 73.03% | EEF1A1 | E9_Da | 12.58 | 96.71% |
30 | SLC4A1 | E18_Da | 11.12 | 59.71% | RPS6 | E2_Dd | 12.19 | 135.19% | AHNAK | E5_Ad | 11.42 | 131.13% | RPS6 | E2_Dd | 12.50 | 213.75% |
31 | HSP90B2P | E2_Da | 11.10 | 62749.66% | ACTA1 | E3_Dc | 12.09 | 132254.83% | HSPA8 | E9_Ab | 11.39 | 57.16% | HLA-A | E4_Da | 12.47 | 169.83% |
32 | PTMA | E7_Dd | 11.08 | 67.81% | HSP90B2P | E2_Da | 12.06 | 69325.98% | FAU | E3_Ab | 11.37 | 145.82% | AC096663.1 | E1_Da | 12.46 | 16466.95% |
33 | LCN2 | E2_Ab | 11.03 | 39.52% | HSP90B2P | E1_Da | 12.04 | 68613.73% | EEF1A1 | E9_Db | 11.34 | 41.63% | UBC | E2_Ag | 12.45 | 43.06% |
34 | EEF1A1 | E9_Db | 10.99 | 55.73% | TPT1 | E5_Da | 11.99 | 68.78% | XBP1 | E6_Da | 11.26 | 78.43% | UBC | E2_De | 12.42 | 42.19% |
35 | FGFR3 | E19_Dc | 10.90 | 64.03% | EEF1A1 | E9_Db | 11.96 | 84.58% | DDX5 | E13_Aa | 11.23 | 45.02% | PTMA | E7_Dc | 12.12 | 145.61% |
36 | FGFR3 | E19_Da | 10.90 | 63.85% | UBC | E2_Ah | 11.96 | 51.31% | PTMA | E2_Ad | 11.19 | 97.73% | SERF2 | E3_Ah | 12.05 | 2417.51% |
37 | PTMA | E7_Dc | 10.83 | 56.90% | GAPDH | E10_Da | 11.94 | 49.81% | PSAP | E11_Ab | 11.18 | 53.88% | AC135457.2 | E3_Ab | 11.98 | 130.07% |
38 | GYPC | E1_Ab | 10.83 | 81.79% | UBC | E2_Al | 11.85 | 47.61% | CANX | E10_Da | 11.13 | 113.12% | EEF1A1 | E9_Db | 11.94 | 61.76% |
39 | SLC4A1 | E18_Ac | 10.82 | 48.75% | HSP90B2P | E2_Aa | 11.82 | 58908.66% | FGFR3 | E19_Da | 11.12 | 43.93% | AC002480.1 | E2_Aa | 11.92 | 7612.92% |
40 | SLC4A1 | E18_Ab | 10.81 | 48.36% | UBC | E2_Ac | 11.74 | 44.15% | IER2 | E2_Ab | 11.05 | 246.28% | PTMA | E4_Db | 11.91 | 125.15% |
41 | UBC | E2_Ac | 10.79 | 24.75% | UBC | E2_De | 11.64 | 41.09% | FGFR3 | E19_De | 11.05 | 41.68% | AL671277.5 | E8_Da | 11.88 | 10660.10% |
42 | HSP90B3P | E3_Aa | 10.79 | 40260.25% | TMSL3 | E1_Ab | 11.62 | 969.97% | SSR4 | E2_Ab | 11.04 | 71.00% | PTMA | E7_Dd | 11.82 | 117.65% |
43 | UBC | E2_De | 10.77 | 24.46% | PTMA | E7_De | 11.59 | 102.32% | AC135457.2 | E3_Ab | 11.03 | 85.37% | HSPA8 | E9_Da | 11.80 | 62.39% |
44 | SLC4A1 | E17_Da | 10.70 | 44.75% | PTMA | E7_Dc | 11.57 | 100.48% | FGFR3 | E19_Ae | 11.00 | 40.27% | TOMM7 | E1_Ab | 11.80 | 359.89% |
45 | IER2 | E2_Ab | 10.66 | 148.32% | AC092268.4 | E1_Da | 11.56 | 25405.73% | COPEB | E2_Dc | 10.93 | 50.97% | PTMA | E2_Ad | 11.77 | 114.09% |
46 | ATP5E | E1_Ac | 10.63 | 586.03% | UBC | E2_Ag | 11.56 | 38.98% | FCRLA | E1_Ab | 10.89 | 207.53% | SSR4 | E2_Ab | 11.71 | 120.50% |
47 | FGFR3 | E19_De | 10.60 | 51.99% | HLA-A | E4_Da | 11.50 | 103.34% | AHNAK | E5_Dc | 10.85 | 88.46% | RPS7 | E2_Ab | 11.64 | 311.43% |
48 | AC135457.2 | E1_Ab | 10.59 | 121.62% | AC096663.1 | E2_Aa | 11.46 | 3867.21% | COPEB | E2_Ac | 10.80 | 46.56% | HSPA8 | E9_Ab | 11.61 | 54.71% |
49 | SLC4A1 | E12_Da | 10.58 | 41.07% | AL671277.5 | E8_Da | 11.46 | 10656.81% | FOSB | E2_Aa | 10.79 | 24.83% | HLA-B | E9_Ab | 11.55 | 21.89% |
50 | ATPIF1 | E1_Ab | 10.57 | 122.30% | PTMA | E7_Dd | 11.45 | 92.80% | TPT1 | E1_Ad | 10.78 | 47.57% | HSPA8 | E7_Da | 11.54 | 51.92% |
51 | RPS8 | E3_Da | 10.57 | 31.32% | PTMA | E2_Ae | 11.44 | 91.91% | FGFR3 | E19_Dc | 10.77 | 34.51% | RPS21 | E2_Ac | 11.54 | 553.55% |
52 | FAU | E3_Ab | 10.56 | 54.95% | RPS7 | E2_Ab | 11.43 | 245.78% | AL109615.42 | E1_Da | 10.77 | 130690.77% | FOSB | E4_Aa | 11.50 | 51.31% |
53 | AL109615.42 | E1_Da | 10.53 | 140600.40% | AC011737.10 | E1_Da | 11.43 | 45429.65% | DDX5 | E12_Da | 10.70 | 31.27% | AL671277.5 | E8_Aa | 11.49 | 8129.10% |
54 | PSAP | E15_Dc | 10.51 | 47.39% | AC010234.5 | E3_Da | 11.34 | 215016.13% | FGFR3 | E19_Ab | 10.68 | 32.22% | ARF1 | E1_Ab | 11.46 | 124.44% |
55 | COPEB | E2_Dc | 10.49 | 79.52% | EEF1A1 | E9_Da | 11.29 | 53.25% | COPEB | E1_Ab | 10.66 | 42.40% | HSP90AB3P | E3_Da | 11.41 | 129432.91% |
56 | ARF1 | E1_Ab | 10.49 | 73.26% | DENND1B | E4_Aa | 11.29 | 31644.60% | HNRPA2B1 | E6_Da | 10.63 | 121.20% | AHNAK | E5_Db | 11.39 | 378.83% |
57 | AC135457.2 | E3_Ab | 10.46 | 111.65% | PSAP | E15_Dc | 11.27 | 74.16% | DERL3 | E4_Da | 10.58 | 99.88% | FCRLA | E1_Ab | 11.37 | 234.02% |
58 | COPEB | E2_Da | 10.46 | 77.60% | IL2RG | E1_Ad | 11.27 | 133.14% | DDX5 | E12_Aa | 10.58 | 28.79% | TPT1 | E1_Ac | 11.35 | 80.93% |
59 | SLC4A1 | E19_Da | 10.45 | 37.61% | EEF1B2 | E1_Ad | 11.25 | 201.50% | CANX | E8_Ab | 10.49 | 72.69% | TPT1 | E5_Da | 11.30 | 78.29% |
60 | PSAP | E11_Ab | 10.44 | 45.15% | ATP5E | E1_Ac | 11.25 | 578.60% | LDHA | E8_Ab | 10.48 | 85.98% | FGFR3 | E19_De | 11.28 | 51.74% |
61 | RPS27A | E6_Da | 10.44 | 60.57% | AC008629.7 | E1_Da | 11.25 | 17324.93% | YBX1 | E5_Da | 10.45 | 97.59% | DDX5 | E13_Aa | 11.24 | 64.63% |
62 | RPL32 | E4_Da | 10.41 | 86.28% | AFMID | E12_Db | 11.23 | 5371.78% | YWHAZ | E11_Dc | 10.45 | 74.47% | FGFR3 | E19_Ae | 11.23 | 49.83% |
63 | IL2RG | E1_Ad | 10.41 | 77.22% | GAPDH | E9_Da | 11.21 | 30.00% | EIF4G2 | E21_Db | 10.44 | 74.19% | IER2 | E2_Ab | 11.23 | 214.93% |
64 | S100A12 | E4_Da | 10.40 | 34.08% | RPS21 | E2_Ac | 11.18 | 394.42% | HSP90AB3P | E3_Da | 10.42 | 46658.47% | RPS29 | E3_Da | 11.22 | 217.23% |
65 | PTMA | E2_Ae | 10.40 | 42.37% | TOMM7 | E1_Ab | 11.18 | 275.38% | SFRS5 | E5_Da | 10.42 | 70.99% | EEF1B2 | E1_Ad | 11.19 | 170.47% |
66 | TPT1 | E1_Ad | 10.40 | 27.15% | BX323046.3 | E1_Da | 11.17 | 17271.57% | AHNAK | E5_Ac | 10.40 | 64.80% | PTMA | E7_De | 11.18 | 75.87% |
67 | HSPA8 | E7_Da | 10.40 | 45.36% | LCN2 | E6_Ab | 11.15 | 23.77% | HSPA8 | E9_Da | 10.37 | 28.23% | AC011444.5 | E3_Aa | 11.17 | 109111.45% |
68 | AL354710.17 | E3_Aa | 10.38 | 58336.84% | AC135457.2 | E1_Ab | 11.08 | 186.78% | CANX | E8_Da | 10.35 | 66.08% | ZNF695 | E4_Dc | 11.09 | 73127.23% |
69 | YBX1 | E1_Da | 10.38 | 67.77% | AL671277.5 | E8_Aa | 11.06 | 8114.28% | TUBA1C | E5_Ab | 10.33 | 1127.11% | SDC1 | E6_Ab | 11.08 | 79.87% |
70 | PRDX2 | E1_Ab | 10.36 | 35.39% | AL671277.5 | E10_Aa | 11.06 | 8102.17% | PTMA | E7_Dc | 10.31 | 52.84% | H3F3A | E5_Da | 11.06 | 3144.36% |
71 | FGFR3 | E19_Ae | 10.35 | 43.62% | ACTA1 | E3_Da | 11.06 | 64726.78% | HSP90AB1 | E11_Db | 10.26 | 47.90% | AL121893.21 | E2_Aa | 11.06 | 160228.52% |
72 | AHNAK | E5_Db | 10.35 | 266.62% | VIM | E9_Aa | 11.05 | 30.29% | YBX1 | E5_Ac | 10.25 | 84.66% | RHOB | E1_Db | 11.05 | 129.34% |
73 | HSPA8 | E9_Da | 10.32 | 43.07% | AL121759.25 | E2_Aa | 11.02 | 29324.11% | CANX | E15_Ab | 10.22 | 60.24% | VIM | E9_Aa | 11.03 | 24.00% |
74 | PTMA | E7_De | 10.31 | 39.79% | RPL23 | E6_Da | 11.00 | 60.67% | SFRS5 | E6_Da | 10.18 | 60.16% | FGFR3 | E19_Da | 11.03 | 43.28% |
75 | COPEB | E1_Ab | 10.28 | 68.82% | AC012652.1 | E7_Ab | 10.96 | 723.36% | PTMA | E7_Dd | 10.12 | 46.36% | FGFR3 | E19_Dc | 11.00 | 42.61% |
76 | FTH1 | E1_Ac | 10.28 | 34.56% | ARPC5 | E1_Ac | 10.94 | 205.19% | TMCO1 | E1_Ab | 10.11 | 64.09% | FGFR3 | E19_Ab | 10.96 | 41.29% |
77 | SERF2 | E3_Ah | 10.26 | 718.09% | HNRNPC | E3_Ab | 10.91 | 256.01% | RHOB | E1_Db | 10.10 | 89.22% | PSAP | E11_Ab | 10.90 | 52.31% |
78 | GRN | E12_Ab | 10.24 | 60.36% | AL354710.17 | E3_Aa | 10.90 | 74533.57% | RPS27A | E6_Da | 10.09 | 82.15% | HSP90AB1 | E11_Db | 10.90 | 68.96% |
79 | MYH9 | E42_Db | 10.24 | 133.83% | NME1-NME2 | E10_Ab | 10.87 | 317.33% | SFRS5 | E8_Da | 10.09 | 56.49% | SDC1 | E6_Da | 10.89 | 70.41% |
80 | YBX1 | E7_Db | 10.20 | 59.95% | GAPDH | E10_Db | 10.86 | 23.63% | XBP1 | E5_Ab | 10.07 | 34.29% | PSAP | E15_Dc | 10.89 | 52.10% |
81 | AHNAK | E5_Ad | 10.20 | 240.52% | HSPA8 | E9_Da | 10.83 | 51.41% | EIF5A | E8_Da | 10.06 | 74.56% | DDX5 | E12_Da | 10.81 | 48.12% |
82 | SLC4A1 | E8_Da | 10.20 | 31.54% | AL354710.17 | E2_Da | 10.80 | 69406.45% | TPM3 | E14_Dc | 10.05 | 349.74% | TPM4 | E10_Db | 10.80 | 214.42% |
83 | FGFR3 | E19_Ab | 10.17 | 38.48% | H3F3A | E5_Da | 10.78 | 2212.96% | TPM4 | E10_Db | 10.02 | 106.51% | FOSB | E2_Aa | 10.77 | 30.85% |
84 | CST3 | E4_Da | 10.15 | 165.80% | UCRC | E2_Da | 10.76 | 438.08% | GAPDH | E10_Db | 10.02 | 26.49% | AHNAK | E5_Ad | 10.76 | 243.89% |
85 | HSPA8 | E9_Ab | 10.15 | 38.16% | AC135457.2 | E3_Ab | 10.74 | 147.55% | NP | E2_Aa | 10.00 | 39.81% | HSP90AB3P | E3_Aa | 10.70 | 78567.99% |
86 | FOSB | E2_Aa | 10.13 | 30.40% | SRRM2 | E16_Ab | 10.71 | 302.75% | XBP1 | E5_Da | 9.97 | 32.02% | AL671277.5 | E6_Aa | 10.68 | 4660.77% |
87 | NME1-NME2 | E10_Ab | 10.11 | 165.09% | LDHA | E8_Da | 10.70 | 103.71% | PNRC1 | E3_Da | 9.87 | 83.10% | RPS21 | E3_Dd | 10.67 | 303.55% |
88 | TUBA1C | E5_Ab | 10.11 | 234.71% | SH3BGRL3 | E3_Db | 10.70 | 143.43% | TMSL3 | E1_Da | 9.84 | 1193.07% | YBX1 | E7_Db | 10.66 | 99.47% |
89 | YBX1 | E5_Da | 10.11 | 56.03% | AC092671.2 | E3_Aa | 10.69 | 5880.05% | PNRC1 | E3_Db | 9.84 | 81.44% | YWHAZ | E11_Dc | 10.62 | 104.47% |
90 | HNRPA2B1 | E6_Da | 10.10 | 111.96% | RPS27A | E6_Da | 10.69 | 64.57% | PABPC4 | E10_Da | 9.79 | 41.42% | CITED2 | E2_Db | 10.59 | 84.46% |
91 | HNRNPAB | E1_Ad | 10.08 | 131.18% | ZNF695 | E4_Dc | 10.69 | 47948.45% | CANX | E15_Da | 9.79 | 44.67% | HSP90AB3P | E2_Da | 10.58 | 72646.39% |
92 | YBX1 | E5_Ac | 10.08 | 54.91% | PTMA | E4_Ab | 10.68 | 54.39% | TPM4 | E11_Aa | 9.78 | 89.75% | HSPA5 | E7_Aa | 10.58 | 28.10% |
93 | FTH1 | E1_Da | 10.07 | 29.80% | AC022443.5 | E1_Da | 10.66 | 22114.37% | FCRL2 | E14_Da | 9.76 | 90.41% | XBP1 | E5_Ab | 10.57 | 46.48% |
94 | GRN | E10_Da | 10.04 | 52.31% | PTMA | E7_Da | 10.66 | 53.50% | TAPBP | E9_Da | 9.75 | 99.95% | AL121893.21 | E1_Da | 10.57 | 113996.65% |
95 | HNRNPC | E3_Ab | 10.00 | 170.09% | FCN1 | E7_Da | 10.66 | 61.03% | TMSB4X | E2_Da | 9.74 | 66.13% | FCRL2 | E14_Da | 10.54 | 93.22% |
96 | HSP90AB3P | E3_Da | 9.98 | 56775.63% | HLA-DRA | E1_Ab | 10.64 | 106.79% | LIN9 | E14_Aa | 9.73 | 2249.60% | AC008629.7 | E1_Da | 10.50 | 32687.24% |
97 | GRN | E6_Da | 9.96 | 49.49% | HSPA8 | E9_Ab | 10.64 | 45.18% | MORF4L2 | E2_Ab | 9.70 | 162.67% | EIF4G2 | E21_Db | 10.50 | 83.40% |
98 | UBL5 | E1_Ab | 9.90 | 128.33% | HSPA8 | E7_Da | 10.64 | 45.18% | LMNA | E14_Da | 9.68 | 60.26% | COPEB | E1_Ab | 10.50 | 93.99% |
99 | AC011737.10 | E1_Da | 9.89 | 19218.54% | TPT1 | E5_Db | 10.62 | 26.47% | SDC1 | E6_Ab | 9.68 | 59.12% | AC135457.2 | E1_Ac | 10.47 | 45.87% |
100 | COPEB | E2_Ac | 9.86 | 51.19% | EEF1A1 | E9_Ab | 10.61 | 33.12% | USF1 | E12_Da | 9.62 | 122.13% | EIF1 | E3_Aa | 10.47 | 23.78% |
101 | PKM2 | E2_Da | 9.86 | 60.03% | PTMA | E2_Ad | 10.61 | 51.57% | GNAS | E4_Dc | 9.62 | 748.86% | SDC1 | E4_Da | 10.47 | 52.58% |
102 | PCNA | E2_Ab | 9.85 | 115.74% | NCOA4 | E10_Da | 10.60 | 132.18% | TOMM7 | E1_Ab | 9.61 | 149.28% | DDX5 | E12_Aa | 10.44 | 37.08% |
103 | SFRS5 | E5_Da | 9.85 | 76.58% | PNRC1 | E3_Da | 10.60 | 110.49% | YBX1 | E7_Ab | 9.59 | 53.53% | BX323046.3 | E1_Da | 10.42 | 51852.15% |
104 | FCN1 | E7_Da | 9.82 | 47.18% | PKM2 | E2_Da | 10.58 | 98.67% | SDC1 | E6_Da | 9.59 | 55.59% | XBP1 | E5_Da | 10.42 | 41.76% |
105 | EIF4G2 | E21_Db | 9.79 | 85.96% | SH3BGRL3 | E3_Dc | 10.58 | 131.66% | SRRM2 | E11_Db | 9.58 | 85.45% | AC012652.1 | E7_Ab | 10.41 | 853.05% |
106 | HBG2 | E9_Db | 9.78 | 882.37% | HNRPA2B1 | E6_Da | 10.57 | 138.43% | HDLBP | E26_Da | 9.57 | 74.16% | AFMID | E12_Db | 10.41 | 3128.31% |
107 | RPS21 | E2_Ac | 9.78 | 74.48% | HSP90AB3P | E3_Da | 10.56 | 35526.21% | CALM2 | E7_Da | 9.55 | 58.04% | RPL15 | E4_Da | 10.40 | 108.47% |
108 | SRRM2 | E16_Ab | 9.76 | 101.57% | TPT1 | E1_Ac | 10.55 | 25.19% | AHNAK | E5_Da | 9.55 | 35.92% | TMSL3 | E1_Da | 10.39 | 2949.44% |
109 | SH3BGRL3 | E3_Db | 9.76 | 74.55% | PSAP | E11_Ab | 10.55 | 44.82% | HSP90AB1 | E13_Ab | 9.53 | 28.88% | CANX | E10_Da | 10.39 | 93.71% |
110 | RAC2 | E8_Da | 9.74 | 70.87% | PNRC1 | E3_Db | 10.53 | 104.81% | TIMP1 | E1_Ab | 9.52 | 64.97% | PNRC1 | E3_Da | 10.38 | 110.32% |
111 | PKM2 | E6_Ab | 9.73 | 54.99% | HMGB1L15 | E1_Dc | 10.51 | 1790.39% | PELI1 | E4_Aa | 9.51 | 49.35% | CALM2 | E7_Da | 10.38 | 102.86% |
112 | PTMA | E4_Ab | 9.73 | 26.52% | RP11-753C18.4 | E1_Da | 10.49 | 172461.90% | HNRNPH1 | E4_Da | 9.51 | 47.89% | GAPDH | E10_Da | 10.37 | 39.72% |
113 | RPL23 | E6_Da | 9.70 | 24.49% | RPS8 | E3_Da | 10.48 | 26.93% | HNRNPH1 | E5_Aa | 9.51 | 47.87% | AL136219.17 | E2_Aa | 10.36 | 2841.03% |
114 | PSAP | E15_Ab | 9.70 | 26.90% | AC010234.5 | E4_Aa | 10.48 | 118454.47% | FCRL5 | E1_Ab | 9.50 | 63.19% | HIST1H2BK | E1_Ab | 10.36 | 171.72% |
115 | CANX | E10_Da | 9.69 | 90.58% | AC011825.13 | E2_Da | 10.47 | 101601.25% | UBL5 | E1_Ab | 9.49 | 128.83% | RHOB | E1_Ab | 10.36 | 79.78% |
116 | ITGB2 | E2_Ad | 9.65 | 75.90% | AL136219.17 | E2_Aa | 10.47 | 2873.34% | GNAS | E4_Db | 9.48 | 681.73% | SSR4 | E4_Aa | 10.34 | 46.69% |
117 | CTSD | E9_Da | 9.63 | 42.06% | AL359851.19 | E3_Aa | 10.46 | 157295.45% | YBX1 | E7_Db | 9.47 | 49.19% | DBI | E1_Ac | 10.34 | 380.43% |
118 | SSR4 | E2_Ab | 9.63 | 40.61% | GSN | E6_Aa | 10.46 | 412.06% | RPL32 | E4_Da | 9.46 | 60.38% | AC006226.4 | E3_Da | 10.33 | 35272.58% |
119 | NCOA4 | E10_Da | 9.63 | 87.41% | SFRS5 | E5_Da | 10.45 | 94.86% | TAPBP | E6_Ab | 9.45 | 80.86% | RPL18A | E3_Aa | 10.33 | 37.98% |
120 | JTB | E1_Ac | 9.61 | 105.34% | PSAP | E15_Ab | 10.41 | 40.81% | AC135457.2 | E1_Ac | 9.43 | 28.01% | AC016734.7 | E2_Aa | 10.33 | 330725.56% |
121 | SFRS5 | E6_Da | 9.56 | 62.78% | SERF2 | E3_Ah | 10.38 | 615.16% | CDK5RAP3 | E5_Da | 9.41 | 50.31% | FCRL5 | E1_Ab | 10.32 | 139.44% |
122 | COMMD6 | E2_Ac | 9.56 | 783.29% | POLR2J2 | E1_Ab | 10.36 | 1935.71% | YPEL5 | E4_Aa | 9.41 | 29.98% | AL671277.5 | E7_Aa | 10.31 | 3587.99% |
123 | SFRS5 | E8_Da | 9.54 | 61.92% | ARPC5 | E4_Da | 10.36 | 137.31% | EIF4G2 | E21_Ab | 9.38 | 35.58% | AHNAK | E5_Dc | 10.30 | 177.65% |
124 | HSP90AA4P | E3_Aa | 9.54 | 330112.23% | C1orf162 | E6_Da | 10.34 | 266.36% | PSMB9 | E2_Ab | 9.36 | 202.96% | JTB | E1_Ad | 10.30 | 164.08% |
125 | HMGA1 | E6_Ab | 9.53 | 95.87% | IFITM2 | E1_Ab | 10.33 | 114.19% | CEACAM21 | E1_Da | 9.36 | 1677.97% | HNRPA2B1 | E6_Da | 10.29 | 108.06% |
126 | PKM2 | E1_Ab | 9.53 | 47.91% | BRCA1 | E14_Da | 10.32 | 4692.04% | CD164 | E6_Ab | 9.35 | 83.86% | AC136619.3 | E30_Aa | 10.29 | 459448.04% |
127 | LDHA | E8_Da | 9.53 | 63.54% | NANOGP1 | E4_Aa | 10.32 | 15973.93% | TPM3 | E14_Da | 9.34 | 213.77% | AL671277.5 | E10_Aa | 10.29 | 3537.91% |
128 | HSP90AB1 | E11_Db | 9.52 | 47.19% | AL589843.9 | E3_Da | 10.31 | 4371.72% | EDEM3 | E20_Db | 9.34 | 69.77% | ATP5E | E1_Ac | 10.28 | 838.01% |
129 | PNRC1 | E1_Da | 9.51 | 95.64% | CTSD | E9_Da | 10.31 | 90.31% | ITM2C | E7_Da | 9.34 | 20.37% | RBM3 | E7_Db | 10.28 | 162.55% |
130 | C20orf149 | E3_Db | 9.47 | 128.38% | AC008279.3 | E5_Da | 10.31 | 155443.59% | TPM3 | E14_Db | 9.32 | 210.75% | CANX | E15_Da | 10.23 | 84.37% |
131 | ITM2C | E7_Da | 9.43 | 33.92% | AC022443.5 | E2_Aa | 10.30 | 17210.18% | LDHB | E1_Ab | 9.32 | 170.40% | PABPC4 | E10_Da | 10.23 | 56.94% |
132 | YBX1 | E7_Ab | 9.43 | 35.06% | EIF4G2 | E21_Db | 10.29 | 90.63% | SDC1 | E4_Da | 9.32 | 46.14% | SLAMF1 | E8_Ab | 10.23 | 78.30% |
133 | RHOB | E1_Ab | 9.43 | 63.60% | TUBA1C | E5_Da | 10.28 | 505.51% | ARPC3 | E2_Aa | 9.31 | 99.03% | HDLBP | E26_Da | 10.23 | 137.72% |
134 | GNAS | E4_Dc | 9.42 | 677.21% | YWHAZ | E11_Dc | 10.28 | 91.53% | PRDX2 | E1_Ab | 9.31 | 85.70% | LDHA | E8_Da | 10.21 | 95.33% |
135 | UCRC | E2_Da | 9.42 | 322.58% | AL671277.5 | E6_Aa | 10.28 | 4701.24% | CFLAR | E5_Da | 9.29 | 49.17% | AC005000.2 | E1_Da | 10.21 | 168.94% |
136 | SDC1 | E4_Da | 9.41 | 80.17% | TPM3 | E14_Dc | 10.27 | 343.64% | NCL | E6_Ab | 9.26 | 45.39% | CST3 | E4_Da | 10.21 | 294.35% |
137 | HBG1 | E3_Db | 9.40 | 334.06% | TPM4 | E11_Aa | 10.27 | 257.24% | SRRM2 | E11_Ab | 9.24 | 67.85% | AL109615.42 | E1_Da | 10.20 | 536862.54% |
138 | ARPC3 | E2_Aa | 9.39 | 57.32% | TMTC1 | E6_Aa | 10.26 | 60189.03% | LDHA | E8_Da | 9.24 | 36.52% | ZNF253 | E4_Da | 10.19 | 1516.66% |
139 | CTSD | E9_Ab | 9.39 | 35.46% | NUP43 | E8_Da | 10.26 | 1919.45% | PECAM1 | E14_Da | 9.23 | 65.60% | PNRC1 | E3_Db | 10.19 | 96.64% |
140 | CALM2 | E7_Da | 9.36 | 62.60% | AHNAK | E5_Db | 10.26 | 351.19% | NCL | E5_Db | 9.23 | 44.53% | HNRNPK | E18_Da | 10.17 | 107.09% |
141 | GRN | E8_Ab | 9.35 | 32.42% | CCT3 | E7_Da | 10.24 | 451.04% | LMNA | E16_Ab | 9.23 | 44.23% | HSPA8 | E9_Aa | 10.17 | 20.09% |
142 | LDHB | E1_Ab | 9.34 | 110.47% | DDX5 | E13_Aa | 10.24 | 48.85% | CD164 | E6_Db | 9.23 | 77.18% | COPEB | E2_Dc | 10.16 | 74.38% |
143 | HMGB1L15 | E1_Ac | 9.34 | 1247.50% | AC090680.11 | E5_Aa | 10.20 | 95614.94% | HNRNPH1 | E4_Aa | 9.21 | 38.95% | RAN | E1_Ab | 10.16 | 220.21% |
144 | BX323046.3 | E1_Da | 9.32 | 8149.19% | RPL36 | E2_Ab | 10.17 | 35.69% | SEL1L | E19_Ab | 9.21 | 53.77% | FAU | E3_Ab | 10.16 | 80.36% |
145 | EIF5A | E8_Da | 9.32 | 49.55% | AL109615.42 | E1_Da | 10.17 | 128148.86% | RHOB | E1_Ab | 9.21 | 48.27% | SELPLG | E2_Ab | 10.09 | 75.54% |
146 | GPRC5D | E3_Da | 9.31 | 84.66% | EIF5A | E8_Da | 10.16 | 99.02% | PECAM1 | E14_Db | 9.19 | 63.94% | PSAP | E15_Ab | 10.08 | 29.69% |
147 | DDX5 | E13_Aa | 9.31 | 28.79% | HSP90AB1 | E13_Ab | 10.15 | 68.75% | FCRL5 | E11_Ab | 9.19 | 50.86% | RPS27A | E6_Da | 10.08 | 30.91% |
148 | TFRC | E19_Da | 9.30 | 59.75% | USHBP1 | E8_Aa | 10.15 | 21153.01% | SET | E12_Db | 9.18 | 99.88% | HSP90AB3P | E1_Da | 10.08 | 51125.52% |
149 | LDHA | E8_Ab | 9.30 | 54.15% | AHNAK | E5_Ad | 10.14 | 325.11% | LENG8 | E15_Da | 9.17 | 75.70% | CAP1 | E14_Db | 10.07 | 109.13% |
150 | SNCA | E2_Ab | 9.29 | 71.44% | AC011444.5 | E3_Aa | 10.14 | 57980.86% | TMBIM6 | E10_Da | 9.17 | 41.79% | HSP90AB1 | E13_Ab | 10.07 | 38.84% |
151 | AP002364.4 | E1_Da | 9.29 | 11998.06% | ZNF253 | E4_Da | 10.14 | 2461.85% | CCNL1 | E7_Aa | 9.16 | 35.69% | SELPLG | E2_Da | 10.07 | 74.60% |
152 | SH3BGRL3 | E2_Ac | 9.28 | 53.53% | SDC1 | E6_Ab | 10.13 | 99.02% | CAP1 | E14_Da | 9.15 | 91.46% | ODC1 | E13_Da | 10.06 | 79.44% |
153 | CITED2 | E2_Ac | 9.27 | 40.46% | ACTA1 | E3_Ab | 10.13 | 33868.46% | LMNA | E19_Da | 9.14 | 41.51% | ACTA1 | E3_Da | 10.05 | 59246.30% |
154 | C6orf48 | E2_Ae | 9.27 | 283.14% | CAP1 | E14_Db | 10.10 | 87.84% | NME1-NME2 | E13_Da | 9.13 | 90.14% | H3F3B | E3_Aa | 10.04 | 39.91% |
155 | XBP1 | E5_Ab | 9.26 | 41.33% | PKM2 | E6_Ab | 10.08 | 69.75% | NCL | E5_Da | 9.13 | 41.54% | SEMA4A | E3_Da | 10.00 | 83.30% |
156 | ITGB2 | E14_Da | 9.25 | 57.50% | HSP90AB3P | E3_Aa | 10.08 | 25429.53% | B4GALT3 | E8_Da | 9.13 | 57.25% | HEATR3 | E15_Ab | 10.00 | 2429.35% |
157 | FCRLA | E1_Ab | 9.25 | 152.59% | COPEB | E2_Da | 10.08 | 129.00% | HNRPA2B1 | E9_Ab | 9.11 | 42.04% | XBP1 | E6_Da | 9.99 | 31.19% |
158 | TOMM7 | E1_Ab | 9.22 | 107.90% | RBM3 | E7_Db | 10.08 | 161.82% | RAC2 | E8_Da | 9.10 | 103.53% | JTB | E1_Ac | 9.98 | 131.45% |
159 | CITED2 | E2_Db | 9.20 | 38.43% | RPL5 | E1_Ab | 10.05 | 32.01% | AC008740.7 | E10_Aa | 9.10 | 496.05% | AHNAK | E5_Ac | 9.96 | 140.16% |
160 | HLA-DRA | E3_Ab | 9.20 | 52.08% | RHOB | E1_Db | 10.04 | 111.50% | TPM4 | E10_Da | 9.09 | 55.67% | RBM39 | E1_Af | 9.94 | 168.41% |
161 | GUK1 | E13_Da | 9.20 | 74.39% | SFRS5 | E8_Da | 10.03 | 71.09% | YWHAZ | E11_Db | 9.09 | 28.92% | CANX | E8_Da | 9.93 | 68.45% |
162 | GLTSCR2 | E9_Da | 9.19 | 32.10% | SFRS5 | E6_Da | 10.03 | 71.07% | STMN1 | E6_Db | 9.09 | 352.40% | FCRLA | E1_Ac | 9.92 | 85.93% |
163 | XBP1 | E5_Da | 9.18 | 39.04% | SLC4A1 | E17_Da | 10.02 | 76.09% | TP53INP1 | E5_Ab | 9.08 | 30.99% | AC092268.4 | E2_Aa | 9.91 | 60706.70% |
164 | SRRM2 | E11_Ab | 9.18 | 67.91% | FAU | E3_Ab | 10.02 | 47.80% | HSP90AB1 | E13_Da | 9.08 | 21.16% | COPEB | E2_Ac | 9.90 | 62.02% |
165 | SRRM2 | E11_Db | 9.17 | 67.57% | FCAR | E1_Ad | 10.01 | 78.10% | NME1-NME2 | E10_Ab | 9.06 | 85.75% | LDHA | E8_Ab | 9.90 | 76.69% |
166 | GLTSCR2 | E8_Ab | 9.17 | 31.60% | GPRC5D | E3_Da | 10.00 | 122.46% | YPEL5 | E4_Da | 9.06 | 23.58% | SELPLG | E2_Db | 9.90 | 66.38% |
167 | AC092671.2 | E3_Aa | 9.16 | 3129.52% | AC020898.6 | E2_Da | 10.00 | 7935.26% | DERL3 | E5_Da | 9.05 | 34.57% | TMCO1 | E1_Ab | 9.89 | 60.74% |
168 | HSP90AB1 | E13_Ab | 9.16 | 36.79% | SSR4 | E2_Ab | 9.99 | 80.95% | HNRNPH1 | E1_Da | 9.05 | 34.82% | SFRS5 | E6_Da | 9.88 | 79.42% |
169 | CANX | E15_Ab | 9.15 | 62.26% | CITED2 | E2_Db | 9.96 | 98.68% | FCRL5 | E19_Da | 9.03 | 45.57% | CANX | E15_Ab | 9.88 | 66.03% |
170 | GNAS | E4_Db | 9.15 | 560.44% | HNRNPH1 | E13_Da | 9.96 | 97.80% | DERL3 | E5_Ad | 9.02 | 33.72% | TMSL3 | E1_Ab | 9.86 | 2048.20% |
171 | CST3 | E2_Ac | 9.14 | 82.55% | CCL5 | E2_Ab | 9.96 | 307.30% | ERGIC3 | E15_Ab | 9.02 | 37.14% | RPL13A | E9_Da | 9.86 | 27.40% |
172 | FCN1 | E9_Ab | 9.14 | 29.49% | HNRNPU | E14_Db | 9.96 | 209.76% | SEPT2 | E19_Da | 9.01 | 67.47% | HLA-A | E4_Db | 9.85 | 27.58% |
173 | HDGF | E7_Ab | 9.14 | 58.66% | HEATR3 | E15_Ab | 9.96 | 1800.23% | NCL | E5_Dc | 9.01 | 38.23% | COPEB | E2_Da | 9.85 | 59.95% |
174 | HSP90AB3P | E1_Da | 9.13 | 31579.28% | CALM2 | E7_Da | 9.95 | 94.96% | LDHA | E6_Da | 9.00 | 30.95% | CAP1 | E14_Dc | 9.84 | 93.06% |
175 | CCL5 | E2_Ab | 9.13 | 202.62% | HLA-DRA | E3_Ab | 9.95 | 65.82% | RBM3 | E7_Db | 9.00 | 73.48% | FCGR2B | E1_Ab | 9.83 | 108.75% |
176 | TPM3 | E14_Db | 9.13 | 218.98% | RAC2 | E8_Da | 9.94 | 82.36% | NCL | E5_Ad | 8.98 | 37.33% | YPEL5 | E5_Aa | 9.83 | 51.69% |
177 | H3F3A | E5_Da | 9.13 | 724.20% | DCST1 | E4_Db | 9.94 | 74696.10% | NCAM1 | E29_Da | 8.97 | 135.37% | SLAMF1 | E2_Da | 9.82 | 59.07% |
178 | PABPC4 | E10_Da | 9.12 | 53.09% | AL109615.42 | E2_Aa | 9.94 | 109357.97% | ERGIC3 | E13_Da | 8.97 | 35.92% | CECR1 | E3_Ac | 9.81 | 172.20% |
179 | IFITM2 | E1_Ab | 9.12 | 78.96% | ARPC3 | E2_Aa | 9.93 | 59.49% | CST3 | E4_Da | 8.97 | 95.36% | LIN9 | E14_Aa | 9.80 | 2501.11% |
180 | HSP90AA6P | E1_Da | 9.11 | 18561.25% | AC136619.3 | E30_Aa | 9.92 | 308795.15% | RAN | E1_Ab | 8.97 | 132.74% | AC004448.3 | E1_Da | 9.80 | 12076.95% |
181 | PCNA | E5_Da | 9.11 | 69.19% | CANX | E10_Da | 9.92 | 85.31% | ANXA6 | E1_Ab | 8.96 | 77.44% | HBB | E4_Da | 9.79 | 36.69% |
182 | RBM3 | E7_Db | 9.11 | 99.92% | AL161742.7 | E2_Aa | 9.92 | 93326.35% | C20orf30 | E6_Da | 8.96 | 74.12% | ACTA1 | E3_Dc | 9.78 | 49309.40% |
183 | CAP1 | E14_Db | 9.09 | 83.40% | KLK7 | E7_Da | 9.91 | 14692.97% | MORF4L2 | E6_Da | 8.96 | 96.72% | AC084398.25 | E3_Aa | 9.78 | 46202.86% |
184 | AC012652.1 | E7_Ab | 9.09 | 355.04% | ATPIF1 | E1_Ab | 9.90 | 153.22% | CAP1 | E14_Db | 8.95 | 79.43% | AL353581.14 | E4_Aa | 9.78 | 584281.26% |
185 | AC005000.2 | E2_Aa | 9.08 | 104.34% | TPM3 | E14_Db | 9.90 | 264.54% | B4GALT3 | E4_Ab | 8.95 | 50.60% | WIPF1 | E11_Db | 9.77 | 299.53% |
186 | RPL15 | E4_Da | 9.07 | 43.64% | MYH9 | E42_Db | 9.90 | 136.00% | YPEL5 | E5_Aa | 8.94 | 21.75% | SFRS5 | E8_Da | 9.76 | 73.06% |
187 | SERBP1 | E1_Ab | 9.07 | 268.06% | AD000092.1 | E2_Aa | 9.89 | 14839.31% | RNF167 | E10_Dc | 8.94 | 129.83% | SSR4 | E2_Aa | 9.76 | 31.09% |
188 | TAGLN2 | E7_Da | 9.06 | 66.00% | AC006226.4 | E3_Da | 9.88 | 28778.74% | FCRLA | E7_Da | 8.94 | 53.52% | C4orf3 | E2_Ac | 9.76 | 215.61% |
189 | HNRPA2B1 | E9_Ab | 9.05 | 54.21% | FCN1 | E9_Ab | 9.88 | 35.60% | HSP90AB3P | E1_Da | 8.93 | 16532.60% | NR4A2 | E9_Da | 9.75 | 111.15% |
190 | TPM3 | E14_Dc | 9.04 | 205.98% | HSP90AB3P | E2_Da | 9.88 | 22072.99% | HNRNPH1 | E2_Da | 8.92 | 31.81% | LY9 | E1_Ac | 9.74 | 184.11% |
191 | XBP1 | E6_Da | 9.03 | 35.05% | AC084398.25 | E3_Aa | 9.88 | 7553.22% | B4GALT3 | E4_Da | 8.92 | 49.60% | TMSB4X | E2_Da | 9.74 | 95.64% |
192 | PSMB9 | E2_Ab | 9.02 | 190.07% | RPL32 | E4_Da | 9.87 | 49.71% | FCRL5 | E11_Aa | 8.92 | 42.21% | HSP90AB1 | E13_Da | 9.74 | 30.96% |
193 | SFRS2 | E1_Db | 9.02 | 69.41% | PPARG | E7_Da | 9.87 | 22416.47% | WDR6 | E6_Ab | 8.92 | 84.00% | HNRNPH1 | E13_Da | 9.74 | 86.71% |
194 | HMGB1L15 | E1_Dc | 9.01 | 990.00% | HSP90AB1 | E11_Db | 9.87 | 56.58% | SFRS5 | E6_Aa | 8.90 | 24.71% | CTHRC1 | E5_Da | 9.74 | 134.55% |
195 | SFRS10 | E1_Ac | 9.00 | 71.65% | AGXT2L2 | E11_Db | 9.86 | 1161.55% | HNRNPH1 | E13_Da | 8.90 | 31.29% | CANX | E8_Ab | 9.73 | 59.49% |
196 | LMNA | E16_Ab | 9.00 | 64.09% | AC090680.11 | E4_Da | 9.85 | 74709.45% | ATPIF1 | E1_Ab | 8.90 | 145.39% | AC069236.27 | E7_Da | 9.73 | 90.93% |
197 | MYEOV2 | E3_Da | 9.00 | 763.37% | SLC4A1 | E18_Da | 9.84 | 67.42% | C4orf3 | E2_Ac | 8.89 | 149.42% | EIF5A | E8_Da | 9.72 | 72.59% |
198 | PRDX3 | E4_Ab | 8.99 | 129.42% | CST3 | E4_Da | 9.84 | 311.00% | RPL15 | E4_Da | 8.89 | 40.23% | YBX1 | E7_Ab | 9.72 | 51.96% |
199 | JTB | E1_Ad | 8.99 | 68.36% | AL096829.17 | E2_Aa | 9.84 | 37390.03% | ACADVL | E11_Aa | 8.88 | 43.81% | DDX5 | E11_Da | 9.72 | 22.50% |
200 | SH3BGRL3 | E3_Dc | 8.98 | 43.57% | CACNB2 | E21_Dd | 9.84 | 13059.73% | C6orf129 | E1_Ab | 8.88 | 199.56% | NME1-NME2 | E10_Ab | 9.71 | 151.63% |
201 | GUK1 | E13_De | 8.98 | 63.83% | RPL15 | E4_Da | 9.84 | 64.69% | CANX | E1_Da | 8.86 | 23.38% | ZNF207 | E2_Da | 9.70 | 720.19% |
202 | RBM12 | E1_Ae | 8.97 | 330.11% | PTMA | E6_Ac | 9.82 | 29.87% | RPL13A | E9_Da | 8.85 | 32.66% | USHBP1 | E8_Aa | 9.70 | 22758.78% |
203 | EIF4G2 | E21_Ab | 8.97 | 48.71% | AC145146.2 | E7_Da | 9.82 | 1534.33% | USF2 | E6_Ab | 8.85 | 81.18% | TPM3 | E14_Dc | 9.70 | 410.56% |
204 | ARPC5 | E1_Ac | 8.97 | 99.23% | GRN | E10_Da | 9.81 | 70.72% | MORF4L1 | E1_Ab | 8.85 | 117.38% | TPM4 | E11_Aa | 9.69 | 98.95% |
205 | DERL3 | E4_Da | 8.96 | 72.34% | DDX5 | E12_Da | 9.81 | 36.18% | YWHAZ | E11_Da | 8.84 | 24.34% | AC009121.8 | E2_Da | 9.69 | 137914.50% |
206 | YWHAZ | E11_Dc | 8.96 | 59.03% | YBX1 | E7_Db | 9.81 | 65.90% | ADIPOR1 | E6_Da | 8.84 | 46.61% | AC006226.4 | E3_Aa | 9.67 | 22332.41% |
207 | AHNAK | E5_Dc | 8.95 | 101.55% | EIF4G2 | E21_Ab | 9.80 | 64.53% | HSP90AA6P | E1_Da | 8.83 | 11032.93% | AC090680.11 | E5_Aa | 9.67 | 154898.99% |
208 | DDX5 | E12_Da | 8.95 | 22.43% | NPL | E7_Da | 9.80 | 1416.21% | GUK1 | E13_De | 8.83 | 160.02% | RPL32 | E4_Da | 9.67 | 82.22% |
209 | NUP43 | E8_Da | 8.95 | 1086.36% | GLRX | E1_Ab | 9.80 | 229.52% | SERF2 | E5_Da | 8.81 | 339.06% | RPL10 | E7_Aa | 9.67 | 30.22% |